SwissEdilab has sold the brands Colon Pure & Ail Noir Oxyprotect to Noreva Pharma
SwissEdilab, a firm specialized in distribution of food supplements, has sold the brands Colon Pure and Ail Noir Oxyprotect to Noreva Pharma.
Noreva Pharma is a French cosmetics laboratory specialized in the development of dermatological care products distributed in drug stores.
This strategic acquisition expands the firm's product range distributed by its sales force. Noreva Pharma, which is very active in the OTC health market in France, had already acquired Phythea in 2016 and the Bergasol brand from Omega Pharma in 2018.
Oaklins' team in France was the sell-side advisor for SwissEdilab in this transaction.
Talk to the deal team
Related deals
OFFIX Holding and Office World Holding bundled their activities into the newly formed JV Office World Group
OFFIX Holding AG and Office World Holding AG have bundled their businesses into the newly founded Office World Group AG. Office World Holding brings its subsidiaries Office World, iba and Tramondi, and OFFIX brings its companies Papedis, Ecomedia, Oridis, Office Leader and DocuServ into the new Office World Group AG. The merger creates a Swiss group that will be represented throughout the country, generating sales of approximately US$400 million with just under 600 employees.
Learn moreCAPZA and RAISE Impact have invested in Oui Care to accelerate its internal and external growth strategies
The shareholders and management of Oui Care have raised funds and restructured its debt for up to US$78.5 million (US$42.2 million for external growth and US$36.3 million in refinancing). This investment will support Oui Care and its management in this new stage of development.
Learn moreHardford has sold its wholly owned subsidiary Hardford Brands to Pharmaxim
Hardford Holding AB has sold Hardford Brands AB to Pharmaxim AB.
Learn more